Calabrese, V., Scapagnini, G., Ravagna, A., Bella, R., Foresti, R., Bates, T.E., Giuffrida Stella, A.M. and Pennisi, G. (2002) Nitric Oxide Synthase Is Present in the Cerebrospinal Fluid of Patients with Active Multiple Sclerosis and Is Associated with Increases in Cerebrospinal Fluid Protein Nitrotyrosine and S-nitrosothiols and with Changes in Glutathione Levels. Journal of Neuroscience Research, 70, 580-587.
https://doi.org/10.1002/jnr.10408

has been cited by the following article:

• TITLE: Serum Level of Vitamin C in a Sample of Egyptian Patients with Multiple Sclerosis

  AUTHORS: Asmaa Ibrahim, Taha K. Alloush, Yousry Abo Elnaga, Mohamed Hamdy, Mohamed M. Fouad

  KEYWORDS: Vitamin C, Multiple Sclerosis

  JOURNAL NAME: Neuroscience and Medicine, Vol.10 No.4, December 27, 2019

  ABSTRACT: Background: Antioxidants such as vitamin C can eliminate free radicles responsible for oxidative stress. Objective: To assess the serum level of vitamin C in a sample of multiple sclerosis (MS) patients to investigate a possible role of vitamin C in the pathogenesis of MS. Subjects and Methods: Forty patients with MS and twenty healthy controls were included in this study. Vitamin C level was estimated for each participant. Results: Serum vitamin C levels were significantly lower among the patients (ranging from 0.28 mg/dL to 0.75 mg/dL with mean 0.47 ± 0.14 mg/dL and median of 0.46 mg/dL) compared to controls (ranging from 0.60 mg/dL to 2.90 mg/dL with mean 1.87 ± 0.61 mg/dL and median of 1.90 mg/dL) (P Conclusion: Patients with MS tended to have low serum vitamin C levels, and younger patients had lower serum levels.